List of SBIR/STTR awards granted to Glucosentient, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Glucosentient, Inc. in July, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL142326-01A1 | Phase I | 225,000 | July 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Glucosentient, Inc. in April, 2021 for $224,018.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI162165-01 | Phase I | 224,018 | April 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Glucosentient, Inc. for $1,418,156.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800054C-0-0-0 | Phase II | 1,418,156 | ||||||||
A STTR Phase I contract was awarded to Glucosentient, Inc. in August, 2016 for $210,971.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41MH111337-01 | Phase I | 210,971 | August 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Glucosentient, Inc. in April, 2017 for $223,500.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD092155-01 | Phase I | 223,500 | April 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Glucosentient, Inc. in July, 2012 for $149,999.0 USD from the National Science Foundation. | SBIR | 1215421 | Phase I | 149,999 | July 1, 2012 | |||||||
A SBIR Phase II contract was awarded to Glucosentient, Inc. in October, 2013 for $750,000.0 USD from the National Science Foundation. | SBIR | 1330934 | Phase II | 750,000 | October 1, 2013 | |||||||
A SBIR Phase I contract was awarded to Glucosentient, Inc. for $192,955.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA035524-01 | Phase I | 192,955 | ||||||||
A SBIR Phase I contract was awarded to Glucosentient, Inc. for $136,794.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK100213-01 | Phase I | 136,794 | ||||||||
A SBIR Phase I contract was awarded to Glucosentient, Inc. in August, 2023 for $269,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DE033314-01 | Phase I | 269,000 | August 17, 2023 |
